| Literature DB >> 22131646 |
Abstract
Oxidants such as superoxide anion, hydrogen peroxide, and myeloperoxidase from activated inflammatory cells in the lower respiratory tract contribute to inflammation and injury. Etiologic agents include inorganic particulates such as asbestos, silica, or coal mine dust or mixtures of inorganic dust and combustion materials found in World Trade Center dust and smoke. These etiologic agents are phagocytosed by alveolar macrophages or bronchial epithelial cells and release chemotactic factors that recruit inflammatory cells to the lung. Chemotactic factors attract and activate neutrophils, eosinophils, mast cells, and lymphocytes and further activate macrophages to release more oxidants. Inorganic dusts target alveolar macrophages, World Trade Center dust targets bronchial epithelial cells, and eosinophils characterize tropical pulmonary eosinophilia (TPE) caused by filarial organisms. The technique of bronchoalveolar lavage in humans has recovered alveolar macrophages (AMs) in dust diseases and eosinophils in TPE that release increased amounts of oxidants in vitro. Interestingly, TPE has massively increased eosinophils in the acute form and after treatment can still have ongoing eosinophilic inflammation. A course of prednisone for one week can reduce the oxidant burden and attendant inflammation and may be a strategy to prevent chronic TPE and interstitial lung disease.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22131646 PMCID: PMC3205778 DOI: 10.1155/2011/407657
Source DB: PubMed Journal: Mediators Inflamm ISSN: 0962-9351 Impact factor: 4.711
Figure 1Suppression of lung eosinophils with prednisone in TPE patients following after diethylcarbamazine therapy. 7±1 days after prednisone therapy there was a reduction in the percent of eosinophils observed in 12 subjects.
Figure 2Reduction in the spontaneous release of oxidants by lavage cells after prednisone therapy in TPE patients following diethylcarbamazine therapy. (a) Superoxide anion. (b) Hydrogen peroxide.